Search Form
First, enter a politician or zip code
Now, choose a category
 

Greg Walden's Public Statements

Office: U.S. House (OR) - District 2, Republican
On The Ballot: Running, Republican for U.S. House - District 2
Date Title
Sept. 21, 2018 Letter to the Hon. Donald J. Trump - Fully Recognize Jerusalem as Capital of Israel
Sept. 13, 2018 Letter to The Honorable Pat Roberts, Chairman of the Senate Committee on Agriculture, Nutrition, and Forestry, The Honorable Debbie Stabenow, Ranking Member of the Senate Committee on Agriculture, Nutrition, and Forestry, The Honorable Micheal Conaway, Chairman of the House Committee on Agriculture, and The Honorable Collin Peterson, Ranking Member of the House Committee on Agriculture - Members Urges Strong Forest Management in Final Farm Bill Conference Report
Sept. 13, 2018 Diana E. Murphy United States Courthouse
Sept. 13, 2018 House Passes Water Infrastructure Package that Includes Drought Relief for Klamath Farmers
Sept. 11, 2018 Greg Walden to Examine Air Quality, Health Impacts of Wildfire Smoke
Sept. 9, 2018 Fox News "Sunday Morning Futures' - Transcript: Interview with Rep. Greg Walden
Sept. 7, 2018 Letter to the Hon. Paul D. Ryan, Speaker of the House and the Hon. Kevin McCarthy, Majority Leader - Upton Urges Immediate Bipartisan Reauthorization of Violence Against Women Act
Sept. 6, 2018 E&C Urges Senate to Move on Self-Driving Car Legislation
Sept. 6, 2018 Hearing of the House Subcommittee on Environment - Opening Statement of Chairman Greg Walden Subcommittee on Environment "Perfluorinated Chemicals in the Environment: An Update on the Respinse to Contamination and Challenged
Sept. 6, 2018 Hearing of the House Subcomittee on Oversight and Investigations - Opening Statement of Chairman Walden Subcommittee on Oversight and Investigations "Examining Federal Efforts to Ensure Quality of Care and Resident Safety in Nursing Homes"
Sept. 6, 2018 House Passes Bill To Expedite Small-Scale LNG Exports
Sept. 5, 2018 Walden Highlights Legislation to Reduce Drug Prices and Increase Control for Patients
Sept. 5, 2018 Hearing of the House Energy and Commerce Committee - Opening Statement of Chairman Walden Energy and Commerce Committee "Twitter: Transparency and Accountability"
Sept. 5, 2018 Walden and Burgess on Release of SAMHSA Grants to Help Combat the Opioid Crisis
Sept. 5, 2018 Hearing of the House Energy and Commerce Committee - Opening Statement of Chairman Walden Energy and Commerce Committee Subcommittee on Health "Opportunities to Improve Health Care"
Sept. 5, 2018 Walden and Burgess on Senate Passage of Bipartisan Bill Reauthorizing the Children's Hospital Graduate Medical Education Program
Aug. 30, 2018 Letter to Pharmacy Benefit Mangers of CVS, EnvisionRXOptions, Express Scripts Holding Company, Humana Inc., Prime Therapeutics, Procare Pharmacy Benefit Manager, Inc., and UnitedHealth Group - Regarding their Role in the Drug Supply Chain
Aug. 30, 2018 Letter to Francis Crosson, MD, Chairman of the Medicare Payment Advisory Commission - Examine Cost Drivers of Health Care
Aug. 27, 2018 Letter to Krista Pedley, Director of Office of Pharmacy Affairs - Bipartisan, Bicameral Leaders Urge Effective Administration of 340B Drug Pricing Program
Aug. 27, 2018 Letter to the Hon. Kirstjen Nielsen, Secretary of Homeland Security - Common Vulnerabilities Exposures (CVE) Program Recommendations
Aug. 27, 2018 Letter to Dr. Jason Providakes, President and CEO of MITRE Corporation - Common Vulnerabilities Exposures (CVE) Program Recommendations
Aug. 20, 2018 Mail Tribune - Fix Broken Policies to Help Restore Forests
Aug. 16, 2018 Walden & Burgess Comment on FDA Approval of Generic EpiPen
Aug. 14, 2018 Walden and Burgess on President Trump Signing Bipartisan Bill Reauthorizing Animal Drug & Animal Generic Drug User Fee Programs
Aug. 14, 2018 Walden and Blackburn on the National Suicide Hotline Improvement Act Becoming Law
Aug. 9, 2018 Letter to the Hon. Mick Mulvaney, Director of the Office of Management and Budget - Consider Economic Consequences of Proposed Drug Rebate Rule
Aug. 6, 2018 Walden and Burgess on FDA's Draft Guidance Promoting New Treatments for Opioid Use Disorder
Aug. 2, 2018 Letter to Mark Trudeau, President and Chief Executive Officer of Mallinckrodt Pharmaceuticals - Greg Walden Presses Opioid Manufacturers About Their Role in Crisis
Aug. 2, 2018 Letter to Saeed Motahari, President and Chief Executive Officer of Insys Therapeutics - Letters Continue Committee's Comprehensive Review of Opioid Epidemic
Aug. 2, 2018 Letter to Craig Landau, President and Chief Executive Officer of Purdue Pharma - Letters Continue Committee's Comprehensive Review of Opioid Epidemic
Aug. 2, 2018 Walden and Blackburn on Senate Passage of the National Suicide Hotline Improvement Act
Aug. 2, 2018 Letter to Heidi King, Acting Administrator of National Highway Traffic Safety Administration and Andrew Wheeler, Acting Administrator of the Environmental Protection Agency - Cmte Sends Letter to NHTSA, EPA on Transparent Fuel Economy Rulemaking Process
Aug. 1, 2018 Walden and Burgess on Administration's Final Rule to Expand Short-Term Insurance Plans
Aug. 1, 2018 Letter to Nine Contract Pharmacies that Participate in the 340B Drug Pricing Program - Letters Follow Report from Nonpartisan Watchdog & #SubHealth Hearing
Aug. 1, 2018 Walden and Burgess on Senate Passage of Bipartisan Bill Reauthorizing Animal Drug & Animal Generic Drug User Fee Programs
July 31, 2018 Letter to Senators Pat Roberts and Debbie Stabenow - Reform Forest Management in Farm Bill
July 27, 2018 Letter to the Hon. Joseph Simons, Chairman of the Federal Trade Commission - E&C Leaders Request FTC Review PBM Mergers
July 25, 2018 Hearing of the Environment Subcommittee of the House Energy and Commerce Committee - Opening Statement of Rep. Walden, Hearing on Background on Renewable Identification Numbers under the Renewable Fuel Standard
July 25, 2018 Hearing of the Communications and Technology Subcommittee of the House Energy and Commerce Committee - Opening Statement of Rep. Walden, Hearing on Oversight of the Federal Communications Commission
July 25, 2018 Greg Walden Discusses Rural Broadband Expansion with FCC Chairman
July 24, 2018 Hearing of the Oversight and Investigations Subcommittee of the House Harper Committee - Opening Statement of Rep. Walden, Hearing on Examining Advertising and Marketing Practices Within the Substance Use Treatment Industry
July 24, 2018 Greg Walden Examines Fraud and Abuse Within Opioid Addiction Treatment Industry
July 24, 2018 Hearing of the Energy Subcommittee of the House Energy and Commerce Committee - Opening Statement of Rep. Walden, Hearing on DOE Modernization: Legislation to Authorize a Pilot Project to Commercialize the Strategic Petroleum Reserve
July 23, 2018 Palliative Care and Hospice Education and Training Act
July 23, 2018 Title VIII Nursing Workforce Reauthorization Act of 2018
July 23, 2018 House Passes Bipartisan Broadband, Public Safety Bills
July 23, 2018 Dr. Benjy Frances Brooks Children's Hospital Gme Support Reauthorization Act of 2018
July 23, 2018 Letter to the Honorable Ajit Pai, Chairman for the Federal Communications Commission - Committee Seeks Update On 9-1-1 Fee Diversion
July 19, 2018 Walden and Burgess Comment on Creation of Working Group to Review Drug Importation
July 19, 2018 Hearing of the Health Subcommittee of the House Energy and Commerce Committee - Opening Statement of Rep. Walden, Hearing on 21st Century Cures Implementation: Examining Mental Health Initiatives
Skip to top

Help us stay free for all your Fellow Americans

Just $5 from everyone reading this would do it.

Thank You!

You are about to be redirected to a secure checkout page.

Please note:

The total order amount will read $0.01. This is a card processor fee. Please know that a recurring donation of the amount and frequency that you selected will be processed and initiated tomorrow. You may see a one-time charge of $0.01 on your statement.

Continue to secure page »

Back to top